悪性 メラノーマ: 日焼け止め の 使用 と がん の リスク の 関係 - 体系 的 な レビュー と メタ 分析
Anne Simone Brunner1, Sinan Haddad2, Julius Johannes Weise3
1Department of Dermatology, Venereology, Allergology, Homburg, Germany.
Anticancer research
|August 28, 2025
まとめ
この研究では,日焼け止めの使用とメラノーマのリスクとの間に有意な関連性が見つかりませんでした. 日焼けの行動や皮膚がん予防への影響を理解するためにさらなる研究が必要です.
科学分野:
- 皮膚科
- エピデミオロジー
- 腫瘍学
背景:
- 太陽放射線は皮膚がんの主な危険因子です
- 悪性メラノーマの発生率は 日焼け防止の意識が高まっているにもかかわらず
- メラノーマに対する日焼け止めの保護作用は不明である.
研究 の 目的:
- 日焼け止めの使用とメラノーマのリスクとの関連を評価する.
- メラノーマに対する保護手段として 日焼け止めの有効性を評価する
主な方法:
- PubMedデータベースからの研究を体系的にレビューし,メタ分析した.
- "これまで"と"決して"の日焼け止め使用者間のメラノーマリスクの比較
- 確率比 (OR) と信頼区間 (CI) を計算し,性別,研究の質,場所の適度分析を行う.
主要な成果:
- 日焼け止めの使用とメラノーマのリスクとの間に有意な関連性が見つかりませんでした (OR=0. 98, 95%CI=0. 79- 1. 21 これまでと決して/稀に; OR=0. 95, 95%CI=0. 75- 1. 20 これまでと決して).
- 研究の間で有意な異質性が見られたが,それは完全に説明できなかった.
- 非対称なファネルプロットと有意なエッガーのテストは潜在的なバイアスを示唆し,慎重に解釈する必要があります.
結論:
- 現在の証拠は,日焼け止めの使用とメラノーマのリスクとの関連性を支持していません.
- 既存の研究における方法論的限界が特定された.
- 日焼け止めの使用頻度や 日焼け止めへの曝露の行動を詳細に調査するには,さらなる研究が必要です.
関連する概念動画
Skin Cancer
4.5K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
4.5K
Cancer Survival Analysis
448
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
448
Pigmentation
2.6K
The color of the skin is influenced by a number of pigments, including melanin, carotene, and hemoglobin. Recall that melanin is produced by cells called melanocytes, which are found scattered throughout the stratum basale of the epidermis. The melanin is transferred to the keratinocytes via melanosomes.
Melanin occurs in two primary forms: eumelanin that provides black and brown pigment and pheomelanin that provides red color. Dark-skinned individuals produce more melanin than those with pale...
Melanin occurs in two primary forms: eumelanin that provides black and brown pigment and pheomelanin that provides red color. Dark-skinned individuals produce more melanin than those with pale...
2.6K
Mutations
39.7K
Mutations are changes in the sequence of DNA. These changes can occur spontaneously or they can be induced by exposure to environmental factors. Mutations can be characterized in a number of different ways: whether and how they alter the amino acid sequence of the protein, whether they occur over a small or large area of DNA, and whether they occur in somatic cells or germline cells.
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
39.7K
Cancer Prevention
6.3K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
6.3K
Hazard Ratio
241
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
241


